Equibles does not estimate personal net worth.
Get an email with a short summary when Firefly Neuroscience, Inc. publishes a filing, an earnings call transcript or a press release.
Get AIFF alertsArun Menawat is recorded as Chairman at Firefly Neuroscience, Inc. (AIFF), Chairman at Profound Medical Corp. (PROF) since January 15, 2027 and CEO at Profound Medical Corp. (PROF). The newest filing on record that lists Arun Menawat as Chairman at Firefly Neuroscience, Inc. (AIFF) is dated July 9, 2026. Profound Medical Corp. reported in an 8-K filed November 12, 2026 that Arun Menawat was appointed Executive Chairman of the Board, effective January 15, 2027. Firefly Neuroscience, Inc. reported in an 8-K filed August 7, 2026 that Arun Menawat was appointed Class III director, effective August 5, 2026. Firefly Neuroscience, Inc. reported in an 8-K filed April 24, 2025 that Arun Menawat was appointed chairperson and member of the Compensation Committee, member of the Audit Committee, and member of the Nominating and Corporate, effective April 18, 2025. Equibles holds 5 filed executive changes naming Arun Menawat; each is listed under recent activity with its source filing. Arun Menawat has spoken on 18 earnings calls and 1 other investor event across 1 company, most recently for Profound Medical Corp. on November 5, 2026. Profound Medical Corp. is classified in the Medical Devices industry within the Healthcare sector. Firefly Neuroscience, Inc. is classified in the Software - Application industry within the Technology sector. Other leadership on record at Profound Medical Corp. includes Richard R. Fabian (CEO), Matthew Sobczyk (CFO), Frank Baylis (Board Member) and 1 other.
“On November 5, 2026, the Board approved a leadership transition plan pursuant to which, effective January 15, 2027 (the “Transition Date”), Richard R. Fabian, the Company’s current President, is appointed President and Chief Executive Officer of the Company, effective as of the Transition Date, and Arun Menawat will step down as Chief Executive Officer and will become Executive Chairman of the Board as of the Transition Date.”
“A proposal to elect Arun Menawat as the Class III director to the Board of Directors (the "Board") to serve until the annual meeting of stockholders to be held in 2029, or until his successor has been duly elected and qualified.”
“We believe that hurdles to change are dropping and a substantive opportunity to grow is upon us. I'm honored and delighted that Rich has joined us to lead the next phase of growth, and I welcome you on behalf of the board of the company.”
“As I discussed in our Q1 call, the dynamics in the prostate disease treatment space continue to change at a rapid pace. Full-blend robotic mastectomy or radiation therapy are the standard of care for treating prostate cancer today.”
“Again, I'm sorry, let me cover Mathieu's part here. So again, Rashed, thank you. Last year, we completed recruitment in CAPTAIN, the first multicenter, randomized, controlled trial directly comparing a new technology to robotic radical prostatectomy for men with localized prostate cancer.”
“As you just heard from Tom, after experimentation and refinement, both his team and their messaging to potential customers, we now know how to sell TULSA programs.”
“As you heard from Mathieu, our clinical story continues to be strong and clear in terms of both the clinical benefits of TULSA and the experience of the patient.”
2027-01-15–present
2025-04-18–present
Start not stated–present
Last confirmed July 9, 2026
Start not stated–2024-12-06
Last confirmed by a filing; no departure on record
Medical Devices · Healthcare
CEO, Chairman
2027-01-15–present
Software - Application · Technology
Chairman
2025-04-18–present
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2024 | Firefly Neuroscience, Inc. (AIFF) | — | — | — |
| 2023 | Firefly Neuroscience, Inc. (AIFF) | — | — | — |
| 2022 | Firefly Neuroscience, Inc. (AIFF) | — | — | — |
